← Browse by Condition
Medical Condition

type 1 hyperlipoprotenemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05816343 Phase 2
Recruiting

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Enrollment
28 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →